These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505 [TBL] [Abstract][Full Text] [Related]
30. Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies. Fusar-Poli P; Berger G J Clin Psychopharmacol; 2012 Apr; 32(2):179-85. PubMed ID: 22367656 [TBL] [Abstract][Full Text] [Related]
31. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia. Browne J; Silver H; Martin R; Hart R; Mergener M; Williams P J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058 [TBL] [Abstract][Full Text] [Related]
32. Use of aripiprazole in tardive dyskinesia: an open label study of six cases. Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247 [TBL] [Abstract][Full Text] [Related]
33. Risperidone in treatment-refractory schizophrenia. Wirshing DA; Marshall BD; Green MF; Mintz J; Marder SR; Wirshing WC Am J Psychiatry; 1999 Sep; 156(9):1374-9. PubMed ID: 10484947 [TBL] [Abstract][Full Text] [Related]
34. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial. Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711 [TBL] [Abstract][Full Text] [Related]
36. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772 [TBL] [Abstract][Full Text] [Related]
37. Buspirone in the treatment of tardive dyskinesia. Moss LE; Neppe VM; Drevets WC J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622 [TBL] [Abstract][Full Text] [Related]
38. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. Shriqui CL; Bradwejn J; Annable L; Jones BD Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951 [TBL] [Abstract][Full Text] [Related]
39. Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. Pappa S; Tsouli S; Apostolou G; Mavreas V; Konitsiotis S Clin Neuropharmacol; 2010; 33(6):271-5. PubMed ID: 21121175 [TBL] [Abstract][Full Text] [Related]
40. Vitamin E in the treatment of tardive dyskinesia. Elkashef AM; Ruskin PE; Bacher N; Barrett D Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]